Organigram Holdings Inc. Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending May 31, 2022 was 27.13% (a 17.29% increase compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -29.03%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 16.92% (a 18.74% increase from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 14.25% (a -91.05% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was 159.18% (a 50.5% increase from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending May 31, 2022 was 27.21% (a -9.06% decrease compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth increased by 113.24% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
31 May '22 28 Feb '22 30 Nov '21 31 Aug '21
27.21% 29.92% 16.46% 12.76%
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of Organigram Holdings Inc.

Most recent Selling, General and Administrative (SG&A) Expenses Growthof OGI including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Organigram Holdings Inc.

Organigram Holdings Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 27.13% 23.13%
2021 20.98% 38.23% 38.73% -18.49% 16.92%
2020 4.95% -29.84% -1.97% 59.26% 14.25%
2019 98.63% 42.54% 2.01% -37.21% 159.18%
2018 -49.65% 105.77%
2017 87.46%
2016 -46.65%

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic